Software Recalls Issues and Challenges

Size: px
Start display at page:

Download "Software Recalls Issues and Challenges"

Transcription

1 ASQ: Meeting the Compliance Challenge Perspectives from Government, Industry and Quality Professionals: April 28, 2010 Software Recalls Issues and Challenges Jeme Wallace Director Regulatory Affairs GE Healthcare Barrington, IL

2 Summary There are challenges in assessing software defects to determine if a recall of the product should be performed. Implementing an adequate risk assessment process is key to this decision. Crossfunctional teams assess risk and implement a recall decision. Several examples are provided for discussion of recall appropriateness. 2/

3 Agenda Recall Regulations US, EU, Canada Complaints Risk Assessment What s a recall? Examples 3/

4 Regulations - US Food and Drug Administration 21 CFR : Recall policy Recall is a voluntary action that takes place because manufacturers and distributors carry out their responsibility to protect the public health and well-being from products that present a risk of injury or gross deception or are otherwise defective. Why carry out this voluntary action? Manufacturers and distributors have a responsibility to protect the public health and well-being from products that present a risk of injury, or are otherwise defective. 21 CFR 806: Corrections and Removals Manufacturers and importers are required to make a report to FDA of any correction or removal of a medical device(s) if the correction or removal was initiated to: reduce a risk to health posed by the device remedy a violation of the act caused by the device which may present a risk to health 4/

5 Regulations EU Medical Device Directives COUNCIL DIRECTIVE 93/42/EEC: Medical Device Directives Article 10: Information on incidents occurring following placing of devices on the market Member States are required to ensure that any information brought to their knowledge regarding incidents involving a medical device is recorded and evaluated for: any malfunction or deterioration in the characteristics/performance of a device any inadequacy in the labeling or the instructions for use which might lead to or might have led to the death of a patient or user or to a serious deterioration in his state of health; any technical or medical reason in relation to the characteristics or performance of a device 5/

6 Regulations Health Canada Health Products and Food Branch Inspectorate Recall Policy POLICY-0016 Recall: any action taken by the manufacturer, importer or distributor of the device to recall or correct the device, or to notify its owners and users of its defectiveness or potential defectiveness, after becoming aware that the device: a) may be hazardous to health b) may fail to conform to any claim made by the manufacturer or importer relating to its effectiveness, benefits, performance characteristics or safety c) may not meet the requirements of the Act or the Regulations. 6/

7 Stand-Alone Software-classification: Examples United States: PACS: Class II (LLZ) Digital Image Storage Device: Class I (LMB) Electronic Medical Record: Currently unclassified Canada: PACS: Class II Digital Image Storage Device: Class I Electronic Medical Record: Class I/II EU: PACS: Class IIa Digital Image Storage Device: Class I Electronic Medical Record: Class I Class I = lowest risk Class IIa/IIb = moderate risk Class III = highest risk 7/

8 Product Complaints/Investigation Complaint Handling procedure Ability to capture all product issues from internal & external sources Cross-functional team: Engineering, Clinical/Medical, RA, QA, Product Surveillance assesses complaint determines if investigation is required performs Risk Assessment cross-checks the Risk Management file recommends adverse event and/or recall reporting 8/

9 Risk Assessment: Based on ISO Categorization of risks are chosen and justified by the product owner Severity of hazard: ex: Minor, Serious, Critical, Catastrophic Probability of occurrence (Pocc): quantitative vs qualitative (may be better for S/W) ex: Improbable, Remote, Occasional, Frequent Likelihood of harm (LOH): ex: Rare, Unlikely, Likely Outcome of risk assessment process is a risk matrix to determine the: Probability of harm (POH): LOH x Pocc = POH, then POH x Severity = final risk rating ex: Acceptable, Risk Mitigation Required, Unacceptable 9/

10 Risk Assessment and Recall Decision Complaint: The lab results of all the patients in the hospital with the last name of Smith are getting placed in the incorrect patient record. Severity: Critical Pocc: Frequent Likelihood: Likely Improbable Remote Occasional Frequent Reportable Recall Minor Serious A A A RMR A RMR RMR UA Critical RMR RMR UA UA Catastrophic RMR UA UA UA 10 /

11 Why is Software Different? Potential for Defects Device (you can see it, touch it) Software defect User error Interoperability Usability/Human factors Requirements incorrect Component tolerances inadequate. Component at EOL Component spec changes Supplier changes: specs, new Sterilization changes Manufacturing changes Stability changes Material/formulation changes Labeling changes Environment Expiration period changes Performance specs Power sources Shock/fire hazards Software Software defect User error Interoperability Usability/Human factors Requirements incorrect What others can you add? 11 /

12 Samples/Examples A software product named BestEver was developed and released over 5 years ago. The system requirements were heavily researched and took into account every potential workflow sequence possible the developers were confident that all bases were covered and released the product for clinical use. Workflow sequences A and B were an instant success, however user sites did not immediately utilize C and D workflows. A year ago, due to an increase in reimbursement for workflow C, a user site began utilizing it. The Complaint Handling Unit noted several complaints from this site regarding this workflow. Investigation demonstrated a software defect in workflow C. If only one user reports the issue, is this a recall? 12 /

13 Samples/Examples A software change was made on BestEver per a user request. The development team completed testing and sent it to the requesting site for acceptance testing. One user at the site follows a specific workflow sequence and likes the change. Another user at the same site follows a different workflow sequence. He does not like the change and detects a S/W defect based on his workflow. Is it desirable to make this change since it uncovered a defect?? Is it a recall? 13 /

14 Samples/Examples Every year the developers of BestEver software test and release an upgrade so that the product continues to be the best ever. User sites are encouraged to install each upgrade and are offered a free stuffed bear when the upgrade is complete. One site decides they have enough stuffed bears for everyone and refuses an upgrade. About 6 months later, the user site detects a defect in their existing software and files a complaint. After investigation by the development team, an adverse event report is filed with the regulatory agency. Is this a software recall? 14 /

15 Samples/Examples The developers of BestEver know that their software can work with other software packages. They even state in the labeling that it is compatible with any other software that uses the commonly used Special Connecting software. A user site decides to connect BestEver software to EvenBetter software using Special Connecting. One day routine upgrades are installed and the system is re-booted. BestEver doesn t work as it did before and a complaint is filed with the developers of BestEver. Investigation into the complaint determines that, while no upgrades were made to BestEver, an upgrade was made on EvenBetter. The changes caused a latent defect in BestEver to become apparent. Is it a recall? 15 /

16 Conclusion In spite of the complexities of software and making decisions on recalls, it s an exciting time to be in this field Changing regulations globally Increase in technology rapidly advancing Great potential to help the public health 16 /

17 Thank you 17 /

The challenges of software medical device regulation.

The challenges of software medical device regulation. The challenges of software medical device regulation. david.grainger@mhra.gov.uk Introduction A brief history of software device regulation A look at the new device regulations 2 Current framework In Vitro

More information

Post Market Surveillance (including PMCF): common non compliances

Post Market Surveillance (including PMCF): common non compliances Post Market Surveillance (including PMCF): common non compliances Jayanth Katta Ph.D Product Specialist & Certification Manager, General Devices Team, Healthcare 1 Overview EU PMS Requirements for Medical

More information

FDA s Final Rule on Medical Device Data Systems Signals Active Regulation of Data Communication Technologies

FDA s Final Rule on Medical Device Data Systems Signals Active Regulation of Data Communication Technologies ADVISORY February 2011 FDA s Final Rule on Medical Device Data Systems Signals Active Regulation of Data Communication Technologies Contacts On February 15, 2011, the U.S. Food and Drug Administration

More information

MEASURE FOR MEASURE: QUALITY METRICS

MEASURE FOR MEASURE: QUALITY METRICS MEASURE FOR MEASURE: QUALITY METRICS PDA Midwest Chapter Dinner Meeting, Northbrook, IL-9 November 2017 Felicia Ford-Rice, Director, Strategic Compliance 2017 PAREXEL INTERNATIONAL CORP. AGENDA Robust

More information

Optimize Your Field Safety Corrective Actions Systems

Optimize Your Field Safety Corrective Actions Systems Optimize Your Field Safety Corrective Actions Systems Patrick Caines, Ph.D. Baxter Healthcare 9 December 2016 1 Agenda International regulatory requirements and expectations for FSCA and recalls Developing

More information

HAZARD IDENTIFICATION AND RISK ASSESSMENT Revision Date: 04/2017

HAZARD IDENTIFICATION AND RISK ASSESSMENT Revision Date: 04/2017 HAZARD IDENTIFICATION AND RISK ASSESSMENT 23.1 PURPOSE 23.1.1 The purpose of this policy is to help employees identify, analyze and apply control strategies to eliminate or reduce hazardous conditions

More information

Health Canada Enforcement of Consumer Products

Health Canada Enforcement of Consumer Products September 27, 2016 Vietnam Buyers Training Health Canada Enforcement of Consumer Products Jerry Wu Regional Manager, Consumer Product Safety Health Canada OVERVIEW Monitoring the Marketplace Inspections

More information

GUIDELINES ON MEDICAL DEVICES

GUIDELINES ON MEDICAL DEVICES Ref. Ares(2016)1982736-26/04/2016 EUROPEAN COMMISSION DG Internal Market, Industry, Entrepreneurship and SMEs Consumer, Environmental and Health Technologies Health technology and Cosmetics MEDDEV 2.7/3

More information

Medical Device Recalls and Part 806

Medical Device Recalls and Part 806 Medical Device Recalls and Part 806 The Importance of Getting It Right Medmarc Insurance September 28, 2016 Steven Niedelman Lead Quality System & Compliance Consultant King & Spalding LLP 1700 Pennsylvania

More information

FDA Medical Device HFE Guidance

FDA Medical Device HFE Guidance W H I T E P A P E R www.makrocare.com U S FDA has established a new Draft Guidance; Applying Human Factors and Usability Engineering to Medical Devices to Optimize Safety and Effectiveness in Design. Manufacturers

More information

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,

More information

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management The Impact of Quality Culture on Quality Risk Management FDA Perspective on Quality Culture; how it Impacts Risk Management Teresa Gorecki Practice Lead Compliance Architects Agenda The WHAT Definitions

More information

Flight Data Monitoring within an Integrated Safety Management System

Flight Data Monitoring within an Integrated Safety Management System Transport Canada Commercial and Business Aviation Flight Data Monitoring within an Integrated Safety Management System CASS 2004 Presentation Overview Historical perspective of safety Overview of SMS SMS

More information

Risk-Based Approach to Software Quality and Validation

Risk-Based Approach to Software Quality and Validation Risk-Based Approach to Software Quality and Validation By Praxis Life Sciences 1925 West Field Court, Suite 125, Lake Forest, IL 60045 praxislifesciences.com +1(847) 295-7160 validationcenter.com Risk

More information

Due diligence in the European medical devices industry

Due diligence in the European medical devices industry Due diligence in the European medical devices industry Alison Dennis, Reed Smith LLP www.practicallaw.com/0-205-5707 As the medical devices industry is highly regulated, determining a target company's

More information

In the huge expanse of Asia, Singapore and

In the huge expanse of Asia, Singapore and New Medical Device Regulation 16 February 2009 By Ames Gross In the huge expanse of Asia, Singapore and Hong Kong are small places. However, after Japan, they are among the most advanced medical markets

More information

IQCP for Commercially Prepared CLSI-Exempt Media

IQCP for Commercially Prepared CLSI-Exempt Media Please note that some references to protocol, publications, performance data etc. are fictitious in this EXAMPLE. Please use your own DATA for your IQCP. The following represents one example of how you

More information

Copyright GCI, LLC Remediation of Legacy Medical Devices

Copyright GCI, LLC Remediation of Legacy Medical Devices Copyright GCI, LLC. 2016 Remediation of Legacy Medical Devices Copyright GCI, LLC. 2016 What Drives Legacy Remediation? Proactive Recertification / CE Mark Audit Readiness M&A / Due Diligence Reactive

More information

MDSAP AUDIT PROCESS. A Manufacturer s Perspective. Connie Hoy EVP Regulatory Affairs Cynosure, Inc.

MDSAP AUDIT PROCESS. A Manufacturer s Perspective. Connie Hoy EVP Regulatory Affairs Cynosure, Inc. MDSAP AUDIT PROCESS A Manufacturer s Perspective Connie Hoy EVP Regulatory Affairs Cynosure, Inc. Cynosure Located in Westford, MA Largest manufacturer of Medical Lasers Second location in Hicksville,

More information

Canadian Market Surveillance Model on Consumer Product Safety

Canadian Market Surveillance Model on Consumer Product Safety OAS Management of Market Surveillance Systems on Consumer Product Safety May 23, 2012 Washington DC, USA Canadian Market Surveillance Model on Consumer Product Safety Keilee Meraw Consumer Product Safety

More information

Application of Quality Risk Management Tools for Cell Therapy Manufacturing

Application of Quality Risk Management Tools for Cell Therapy Manufacturing Application of Quality Risk Management Tools for Cell Therapy Manufacturing 17 th ISCT Annual Meeting May 20, 2011 Jean Stanton Associate Director, Product Quality Management Janssen Supply Chain Conflict/Disclaimer

More information

HSE Integrated Risk Management Policy. Part 3. Managing and Monitoring Risk Registers Guidance for Managers

HSE Integrated Risk Management Policy. Part 3. Managing and Monitoring Risk Registers Guidance for Managers HSE Integrated Management Policy Part 3 Managing and Monitoring Registers Guidance for Managers HSE Integrated Management Policy Part 3 Managing and Monitoring Registers Guidance for Managers Identify

More information

Korean Medical Devices Regulations

Korean Medical Devices Regulations Korean Devices Regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall responsibility for Devices. The Korea Food and Drug Administration (MFDS), an agency under MHW,

More information

Serious Adverse Event Reporting During European Device Clinical Investigations

Serious Adverse Event Reporting During European Device Clinical Investigations regulations and standards Serious Adverse Event Reporting During European Device Clinical Investigations In December 2010, two new European guidelines on medical device clinical studies were published.

More information

Safety Management Introduction

Safety Management Introduction Safety Management Introduction Eduardo Chacin Regional Officer, Flight Safety ICAO NACC Regional Office Workshop St. Jonhs, Antigua and Barbuda Contents 1. Safety Management Fundamentals 2. ICAO SARPs

More information

PHARMA CONGRESS. Pharmacovigilance and Drug Safety: Assessing Future Regulatory and Compliance Developments. October 28, 2008

PHARMA CONGRESS. Pharmacovigilance and Drug Safety: Assessing Future Regulatory and Compliance Developments. October 28, 2008 PHARMA CONGRESS October 28, 2008 Pharmacovigilance and Drug Safety: Assessing Future Regulatory and Compliance Developments Beverly H. Lorell, MD Senior Medical & Policy Advisor King & Spalding LLP Assessing

More information

Utilization of UDI during the Product Recall. 18 September 2015 Terumo Cardiovascular Group Eileen Dorsey

Utilization of UDI during the Product Recall. 18 September 2015 Terumo Cardiovascular Group Eileen Dorsey Utilization of UDI during the Product Recall 18 September 2015 Terumo Cardiovascular Group Eileen Dorsey 1 Speaker Biography Director, Corporate Post Market Surveillance, Terumo Cardiovascular Group 16

More information

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec 2004 Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland cca@iol.ie 1 FDA Context 1) FDA 5-Part Strategic Plan Protect &

More information

Pharmacovigilance. Training session for patients and consumers involved in EMA activities, 25 November Presented by: Priya Bahri

Pharmacovigilance. Training session for patients and consumers involved in EMA activities, 25 November Presented by: Priya Bahri Pharmacovigilance Training session for patients and consumers involved in EMA activities, 25 November 2014 Presented by: Priya Bahri An agency of the European Union 2 Pharmacovigilance - the science concerned

More information

ZOLL Document Number: 90E0004 Page 5 of 15 Maintenance of Quality Records

ZOLL Document Number: 90E0004 Page 5 of 15 Maintenance of Quality Records ZOLL Number: 90E0004 Page 5 of 15 1. INTRODUCTION 1.1 Purpose 1.2 Scope The purpose of this document is to provide guidance regarding the identification of a quality record and the documentation practices

More information

PROPOSED DOCUMENT. Global Harmonization Task Force

PROPOSED DOCUMENT. Global Harmonization Task Force PROPOSED DOCUMENT Global Harmonization Task Force Title: Quality management system Medical devices - Nonconformity Grading System for Regulatory Purposes and Information Exchange Authoring Group: Study

More information

RISK MANAGEMENT POLICY

RISK MANAGEMENT POLICY RISK MANAGEMENT POLICY Clinical Governance & Risk Management Department Warning Document uncontrolled when printed Policy Reference: RM 2.0 Date of Issue: TBC Prepared by: Risk Management Short Life Date

More information

ZOLL Document Number: 90E0021 Page 6 of 50 QUALITY SYSTEM MANUAL ZOLL Document Number: 90E0021 Page 7 of 50 1 EXECUTIVE MANAGEMENT APPROVAL... 10 2 INTRODUCTION... 11 3 QUALITY SYSTEM... 12 3.1 QUALITY

More information

Medical Device Product Development for Startups

Medical Device Product Development for Startups Medical Device Product Development for Startups - The Bitter Pill AZBIO WEEK / CEI 8/19/2016 ERIC MILLER PADT, INC. Agenda Introduction Medical Device Development Fundamentals The Design Process Manufacturing

More information

So, How Will You Audit a Risk Assessment in ISO 9001:2015?

So, How Will You Audit a Risk Assessment in ISO 9001:2015? So, How Will You Audit a Risk Assessment in ISO 9001:2015? Bob Deysher Senior Consultant Quality Support Group, Inc. bob.deysher@qualitysupportgroup.com 2017 QSG, Inc. Inc. Questions? Does ISO 9001:2015

More information

Providing a workplace free from recognized hazards and complying with OSHA standards Maintain conditions and adopt practices reasonably necessary to protect workers on the job Be familiar with the standards

More information

Incorporating Risk Management into Complaint and Service Experience. Presented by: Richard J. DeRisio, M.S. Kinetic Concepts, Inc.

Incorporating Risk Management into Complaint and Service Experience. Presented by: Richard J. DeRisio, M.S. Kinetic Concepts, Inc. Incorporating Risk Management into Complaint and Service Experience Presented by: Richard J. DeRisio, M.S. Kinetic Concepts, Inc. 1 Management of Complaint and Service Experience A Compliance Headache?

More information

Clause-byclause. Interpretation. Transitioning to ISO 9001:2015

Clause-byclause. Interpretation. Transitioning to ISO 9001:2015 We re committed to helping you and your organization understand the updated requirements. This guidance document identifies the steps you should take to achieve compliance to ISO 9001:2015, and more importantly;

More information

Expanded Access and the Individual Patient IND

Expanded Access and the Individual Patient IND Expanded Access and the Individual Patient IND Research Wednesdays April 26, 2017 Erika Segear Johnson, PhD, RAC Associate Director of Regulatory Affairs Office of Regulatory Affairs and Quality Office

More information

Post Market Surveillance

Post Market Surveillance Post Market Surveillance December 6 th, 2017 Michael Maier, Medidee Services Slide 1 Agenda Postmarket surveillance Postmarket clinical follow up (PMCF) Incident reporting What changes with MDR Slide 2

More information

Getting Started with Risk in ISO 9001:2015

Getting Started with Risk in ISO 9001:2015 Getting Started with Risk in ISO 9001:2015 Executive Summary The ISO 9001:2015 standard places a great deal of emphasis on using risk to drive processes and make decisions. The old mindset of using corrective

More information

Strategies for Risk Based Validation of Laboratory Systems

Strategies for Risk Based Validation of Laboratory Systems Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,

More information

DISTRIBUTION AND SUPPLY OF PLASMA DERIVED FRACTIONATED BLOOD PRODUCTS AND RECOMBINANT PRODUCTS IN NEW ZEALAND

DISTRIBUTION AND SUPPLY OF PLASMA DERIVED FRACTIONATED BLOOD PRODUCTS AND RECOMBINANT PRODUCTS IN NEW ZEALAND REASON FOR CHANGE: Wholesaler s licences are now issued by the Ministry of Health rather than Medsafe; clarify the approval process for the supply of products only to authorised facilities and healthcare

More information

ISO 14001:2015. Control of Environmental Aspects & Impacts.

ISO 14001:2015. Control of Environmental Aspects & Impacts. www.iso-9001-checklist.co.uk Insert your company s name or logo, and address. This procedure is the property of Your Company. It must not be reproduced in whole or in part or otherwise disclosed without

More information

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1 AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward, Owner, Ward Sciences

More information

Pre-Clinical Testing for Devices and Diagnostics

Pre-Clinical Testing for Devices and Diagnostics Pre-Clinical Testing for Devices and Diagnostics Larry O. Blankenship Evergreen Research, Inc. April, 2016 1 Many Levels, Many Approaches The requirements differ dramatically by class and category and

More information

Regulations governing the application of medical accelerators

Regulations governing the application of medical accelerators Regulations governing the application of medical accelerators in 50 minutes. marko.mehle@cosylab.com 2 1.The wonderland of STANDARDS AND REGULATIONS 3 Laws and standards Medical devices (and systems) are

More information

FDA s Guidance for Industry

FDA s Guidance for Industry Sterile Drug Products Produced by Aseptic Processing - CGMPs Midwest FDC Conference November 4 2005 Susan Bruederle, Investigator FDA / ORA / Central Region Chicago District / Hinsdale IL FDA s Guidance

More information

GUIDELINES ON MEDICAL DEVICES GUIDE FOR COMPETENT AUTHORITIES IN MAKING AN ASSESSMENT OF CLINICAL INVESTIGATION NOTIFICATION

GUIDELINES ON MEDICAL DEVICES GUIDE FOR COMPETENT AUTHORITIES IN MAKING AN ASSESSMENT OF CLINICAL INVESTIGATION NOTIFICATION EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Cosmetics and Medical Devices MEDDEV 2.7.2 December 2008 GUIDELINES ON MEDICAL DEVICES GUIDE FOR COMPETENT AUTHORITIES IN

More information

The SMS Table. Kent V. Hollinger. December 29, 2006

The SMS Table. Kent V. Hollinger. December 29, 2006 The SMS Table Kent V. Hollinger December 29, 2006 This presentation introduces the concepts contained in a Safety Management System (SMS) by using the analogy of an SMS being a four-legged glass-top table,

More information

The interface between Good Clinical Practice and Good Manufacturing Practice

The interface between Good Clinical Practice and Good Manufacturing Practice 1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who

More information

HP Standard Supplier Requirements for Safe and Legal Products

HP Standard Supplier Requirements for Safe and Legal Products HP Standard 014-2 Supplier Requirements for Safe and Legal Products Document Identifier Revision and Date Last Revalidation Date Abstract Applicability Status HX-00014-02 G, This standard describes HP

More information

GS1 Ireland Healthcare User Group (HUG) Information Day

GS1 Ireland Healthcare User Group (HUG) Information Day GS1 Ireland Healthcare User Group (HUG) Information Day Regulatory update Medical Devices and the impact for Irish Healthcare Sinead Duggan, HPRA 28 th March 2017 29/03/2017 2 Medical Devices Regulation

More information

Guide for Distributors of Medical Devices

Guide for Distributors of Medical Devices Guide for Distributors of Medical Devices IA-G0004-1 8 FEBRUARY 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS 1 SCOPE 3

More information

Welcome ISO9001:2015 /ISO14001:2015

Welcome ISO9001:2015 /ISO14001:2015 Welcome ISO9001:2015 /ISO14001:2015 DQS 2017 All rights reserved. Unless otherwise specified, no part of this publication may be reproduced or utilized otherwise in any form or by any means, electronic

More information

Clinical Integration Track: It s All About the Data

Clinical Integration Track: It s All About the Data Clinical Integration Track: It s All About the Data Presenters: Sandi Michel, Director of Systems & Quality The Office of Data Standards & Interoperability Franciscan Missionaries of Our Lady Health System

More information

ASQ Tappan Zee Section Medical Devices, New Regulations and Standards. 26 th September / V. Fischer / Rev. 01

ASQ Tappan Zee Section Medical Devices, New Regulations and Standards. 26 th September / V. Fischer / Rev. 01 ASQ Tappan Zee Section Medical Devices, New Regulations and Standards 26 th September / V. Fischer / Rev. 01 Agenda Medical Device, General Aspects Examples Quality System(s) New Regulations & Standards

More information

Medical Device Directive

Medical Device Directive Medical Device Directive WG9 - IEC/SC 62A ISO/TC 184/SC 2 Joint Working Group 9 Saeed Zahedi 4 th of July 2012 Blatchford Copyright 2012 Commercial in confidence Definition and Requirements MDD is law,

More information

The Integration and Application of ISO 9001 and the NIAHO Requirements In Medical Equipment Management

The Integration and Application of ISO 9001 and the NIAHO Requirements In Medical Equipment Management BUSINESS ASSURANCE The Integration and Application of ISO 9001 and the NIAHO Requirements In Medical Equipment Management Randall Snelling 20 October 2017 1 DNV GL 2017 20 October 2017 SAFER, SMARTER,

More information

Forest Stewardship Council

Forest Stewardship Council Introduction Frequently Asked Questions (FAQs) FSC-STD-40-004 V3-0 and FSC-STD-20-011 V4-0 27 March 2017 On 1 January 2017, the FSC Board of Directors approved the revised FSC chain-ofcustody standards

More information

GUIDE TO INSPECTIONS OF QUALITY SYSTEMS

GUIDE TO INSPECTIONS OF QUALITY SYSTEMS FOOD AND DRUG ADMINISTRATION GUIDE TO INSPECTIONS OF QUALITY SYSTEMS 1 1 August 1999 2 Guide to Inspections of Quality Systems This document was developed by the Quality System Inspections Reengineering

More information

ISPE Annual Meeting 29 October 1 November 2017 San Diego, CA

ISPE Annual Meeting 29 October 1 November 2017 San Diego, CA Post Marketing Safety Reporting (PMSR) Challenges and Successful Practices for Combination Products Objective Session Goals Summary of the final rule Interpretation for combination products approved as

More information

Challenges and Opportunities in the Development of integrated Drug Device Combination Products CMC Strategy Forum, Tokyo, 5 December 2017

Challenges and Opportunities in the Development of integrated Drug Device Combination Products CMC Strategy Forum, Tokyo, 5 December 2017 Challenges and Opportunities in the Development of integrated Drug Device Combination Products CMC Strategy Forum, Tokyo, 5 December 2017 F. Wildenhahn, Human Factors Engineering & U. Grauschopf, Head

More information

Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior

Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior Regulatory and Compliance Counsel, BioTeknica Panelists:

More information

Quality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017

Quality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017 Quality Systems Indian Pharmaceutical Alliance Advanced GMP Workshops 2017 Presented by Patrick Costello on November 2017 Principal Scientific Administrator Manufacturing & Quality Compliance An agency

More information

Medical Device Biocompatibility: ISO TC194 Overview & Standards

Medical Device Biocompatibility: ISO TC194 Overview & Standards Medical Device Biocompatibility: ISO TC194 Overview & 10993 Standards Jon Cammack, PhD AstraZeneca/MedImmune R&D/Clinical Quality United States Head of Delegation (HoD), ISO TC194 Convenor, ISO TC194/WG15

More information

MEDICAL DEVICE. Technical file.

MEDICAL DEVICE. Technical file. MEDICAL DEVICE Technical file www.icaro-research.eu ICARO MDTF v1.0 1 Mar 2016 1. Do you plan to launch your medical device in Europe? If you re reading this, chances are good that you re considering introducing

More information

SUBJECT: INSTITUTIONAL REVIEW BOARD (IRB) - HUMANITARIAN USE DEVICES

SUBJECT: INSTITUTIONAL REVIEW BOARD (IRB) - HUMANITARIAN USE DEVICES This policy applies to the following entity(s): Children s Hospital of Wisconsin Children s Hospital and Health System, Inc. Administrative Policy and Procedure Children s Research Institute SUBJECT: INSTITUTIONAL

More information

Available online at ScienceDirect. Procedia Engineering 132 (2015 )

Available online at  ScienceDirect. Procedia Engineering 132 (2015 ) Available online at www.sciencedirect.com ScienceDirect Procedia Engineering 132 (2015 ) 811 815 The Manufacturing Engineering Society International Conference, MESIC 2015 Metrological Regulations for

More information

Work Health and Safety Compliance Training. Course Outline

Work Health and Safety Compliance Training. Course Outline Work Health and Safety Compliance Training Course Outline Module 1 What is work health and safety? 1. define work health and safety (WHS) 2. explain why WHS is important in the workplace 3. explain the

More information

Chapter 1. Pharmaceutical Industry Overview

Chapter 1. Pharmaceutical Industry Overview Chapter 1 Pharmaceutical Industry Overview 1.1 Introduction 2 1.2 Regulations 2 1.2.1 Health Insurance Portability and Accountability Act 2 1.2.2 The Code of Federal Regulations 3 1.2.3 Guidance for Industry

More information

Maintaining your Investigational Device Exemption (IDE) with the FDA: Keys for Success. Jenna Stump, MS, CCRP Clinical Research Regulatory Specialist

Maintaining your Investigational Device Exemption (IDE) with the FDA: Keys for Success. Jenna Stump, MS, CCRP Clinical Research Regulatory Specialist Maintaining your Investigational Device Exemption (IDE) with the FDA: Keys for Success Jenna Stump, MS, CCRP Clinical Research Regulatory Specialist Agenda How an investigator should prepare and submit

More information

ISO 22000:2005 Standard INTERNATIONAL STANDARDS REGISTRATIONS

ISO 22000:2005 Standard INTERNATIONAL STANDARDS REGISTRATIONS ISO 22000:2005 Standard Food Safety Management System INTERNATIONAL STANDARDS REGISTRATIONS 3.1 FOOD SAFETY concept that food will not cause harm to the consumer when it is prepared and/or eaten according

More information

The Risk Management + Design Controls Connection: What Device Makers Need to Know

The Risk Management + Design Controls Connection: What Device Makers Need to Know !!! The Risk Management + Design Controls Connection: What Device Makers Need to Know Jon Speer Founder & VP of QA/RA greenlight.guru Table of Contents 1 Intended Use & User Needs 6 Verification, Validation,

More information

Mastering compliance for medical device solutions

Mastering compliance for medical device solutions Mastering compliance for medical device solutions Business best practices Identifying risks and documenting mitigation is a daunting task for medical device manufacturers. Next-generation application lifecycle

More information

FDA Initiatives and Regulatory Trends for Life Sciences. Larry Spears President L. Spears Consulting

FDA Initiatives and Regulatory Trends for Life Sciences. Larry Spears President L. Spears Consulting FDA Initiatives and Regulatory Trends for Life Sciences Larry Spears President L. Spears Consulting Before We Begin If you experience technical problems, please contact GoToMeeting Technical Support at

More information

IT Compliance in the FDA Regulated Industry. IT Responsibilities 10 Years Ago TODAY! 11/17/2008. Business. Security. Compliance. IT & Automation Forum

IT Compliance in the FDA Regulated Industry. IT Responsibilities 10 Years Ago TODAY! 11/17/2008. Business. Security. Compliance. IT & Automation Forum IT Compliance in the FDA Regulated Industry IT & Automation Forum November 13, 2007 Caribe Hilton, San Juan Puerto Rico Speaker: Mr. Juan O. Pérez, Principal Consultant joperez@fdcpr.com IT Responsibilities

More information

Global Product Safety: Trends & Updates CANADA. Teresa Dufort December 4, 2012 McMillan LLP

Global Product Safety: Trends & Updates CANADA. Teresa Dufort December 4, 2012 McMillan LLP Global Product Safety: Trends & Updates CANADA Teresa Dufort December 4, 2012 McMillan LLP What Hasn t Changed CCPSA Prohibitions Outline Mandatory Incident Reporting What Is New? New Guidance on Mandatory

More information

HEALTH AND SAFETY STRATEGY

HEALTH AND SAFETY STRATEGY HEALTH AND SAFETY STRATEGY 2016-2019 Version: 1.0 Ratified by: Integrated Governance Committee Date ratified: 30 September 2015 Title of originator/author: Title of responsible committee/group: Head of

More information

THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES

THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES Agnette de Perio Peralta and Maria Cecilia Credo Matienzo (apperalta@co.doh.gov.ph and mccmatienzo@yahoo.com) Center for Device

More information

Best Practices: Integration of Risk Management and Corrective and Preventive Action

Best Practices: Integration of Risk Management and Corrective and Preventive Action Best Practices: Integration of Risk Management and Corrective and Preventive Action Presented by: Norman L. Collazo Worldwide Director of Strategic Quality Cordis Corporation, a Johnson & Johnson company

More information

Global Compliance Trends and Warning Letters

Global Compliance Trends and Warning Letters Contact: Charles Lu Director, Quality Carlsbad Tech Phone: (760) 431-8284 Fax: (203) 555-0101 5928 Farnsworth Ct Carlsbad, CA, 92008 www.carlsbadtech.com Global Compliance Trends and Warning Letters Governance

More information

This article specifically covers incorporation of physical and chemical indicators (PCIDs) into or onto the drug product.

This article specifically covers incorporation of physical and chemical indicators (PCIDs) into or onto the drug product. Introduction The pharmaceutical industry is criminalized with circulation of counterfeit drugs risking healthcare and the life of users. This has become quite menacing in recent times with the lure of

More information

Regulatory. Supplier Qualification A Review

Regulatory. Supplier Qualification A Review Supplier Qualification A Review Abstract: It is a GMP requirement to certify the vendor to deliver high quality and safe medicines, and to prevent recalls, deaths, adverse events, and serious illness due

More information

An Introduction to the Worldwide Regulatory Framework for Medical Devices. Elizabeth Malo M.S., Director, Regulatory Affairs

An Introduction to the Worldwide Regulatory Framework for Medical Devices. Elizabeth Malo M.S., Director, Regulatory Affairs An Introduction to the Worldwide Regulatory Framework for Medical Devices Elizabeth Malo M.S., Director, Regulatory Affairs Course Outline / Agenda» Overview Device Regulatory Framework» US/EU/Canada Premarket

More information

STATE OF NORTH CAROLINA

STATE OF NORTH CAROLINA STATE OF NORTH CAROLINA DEPARTMENT OF AGRICULTURE & CONSUMER SERVICES STANDARDS DIVISION LIQUEFIED PETROLEUM GAS SECTION FINANCIAL RELATED AUDIT VIOLATION ENFORCEMENT INVESTIGATION FOLLOW-UP OCTOBER 2013

More information

Examining the New SQF Quality Code: How to Comply by the January Deadline

Examining the New SQF Quality Code: How to Comply by the January Deadline Examining the New SQF Quality Code: How to Comply by the January Deadline Frank Schreurs, Regional Representative, Safe Quality Food Institute Jeff Chilton, VP of Professional Services, Alchemy Systems

More information

Delta Dental of Michigan, Ohio, and Indiana. Compliance Plan

Delta Dental of Michigan, Ohio, and Indiana. Compliance Plan Delta Dental of Michigan, Ohio, and Indiana Compliance Plan Procedure #: 420-29 Issue Date: 5/15/2013 Last Revised Date: 5/23/2016 Last Review Date: 5/23/2016 Next Review Date: 5/23/2017 Title: Compliance

More information

Validating electronic source data in clinical trials

Validating electronic source data in clinical trials Controlled Clinical Trials 25 (2004) 437 446 www.elsevier.com/locate/conclintrial Validating electronic source data in clinical trials Ronald G. Marks* Department of Biostatistics, College of Medicine,

More information

Risk Based Inspection in the Oil and Gas Industry

Risk Based Inspection in the Oil and Gas Industry Risk Based Inspection in the Oil and Gas Industry Speaker s Experience in Oil and Gas U.S Coast Guard Marine Inspector Retired From U.S. Coast Guard 1997 last 6 years of which were inspecting Mobile Operated

More information

A New Era in Quality Control: Developing an IQCP for Your Laboratory

A New Era in Quality Control: Developing an IQCP for Your Laboratory A New Era in Quality Control: Developing an IQCP for Your Laboratory Gerald A. Capraro, Ph.D., D(ABMM) Medical Director, Clinical Microbiology & Diagnostic Virology Laboratories LSU Health Sciences Center

More information

RCM Theory and Concepts Workshop Module 2- RCM Process Overview

RCM Theory and Concepts Workshop Module 2- RCM Process Overview RCM Theory and Concepts Workshop Module 2- RCM Process Overview For Official Use Only Agenda RCM Process Introduction Planning & Preparation RCM Analysis Equipment Kick-off Meeting Initial Data gathering

More information

Mitigating Medical Device Risk through Human Factors. Christina Mendat, PhD Director, Research & Human Factors

Mitigating Medical Device Risk through Human Factors. Christina Mendat, PhD Director, Research & Human Factors Mitigating Medical Device Risk through Human Factors Christina Mendat, PhD Director, Research & Human Factors A profound statistic one-third of medical device incidents involve user error and more than

More information

FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru

FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru FDA QSR (21 CFR Part 820) ISO 13485:2016 820.1 Scope 1 Scope 2 Normative References 820.3 Definitions 3 Terms and Definitions

More information

FDA Update on Compounding

FDA Update on Compounding FDA Update on Compounding Julie Dohm, JD, PhD Senior Science Advisor for Compounding, Center for Drug Evaluation and Research; Agency Lead on Compounding, FDA Compounding A Snapshot Compounded drugs: Are

More information

Software Regulation: The Transfusion Medicine Experience

Software Regulation: The Transfusion Medicine Experience AMIA Invitational Policy Meeting September 9-10, 2009 Software Regulation: The Transfusion Medicine Experience Rodeina Davis Vice President & CIO Milwaukee, WI Founded 60 Years Ago, BloodCenter of Wisconsin

More information

UPPLIER ANUAL. Issued: 01 Aug 13

UPPLIER ANUAL. Issued: 01 Aug 13 UPPLIER ANUAL Issued: 01 Aug 13 Table of Contents Our Company 3 Our Vision 3 Scope and Purpose 4 Responsibilities 4 General Expectations and Requirements 5 Supplier Quality Management System 6 Supplier

More information

UNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014

UNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014 UNIQUE DEVICE IDENTIFICATION U.S. FDA March 2014 Introduction The Food and Drug Administration (FDA) has released a final rule requiring most medical devices distributed in the United States to carry a

More information

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Trinity College Dublin QP Forum 2017 Tuesday 25 th April Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current

More information